Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Salmeterol xinafoate

Known as: Salmeterol Xinafoate [Chemical/Ingredient], Xinafoate, Salmeterol 
A selective ADRENERGIC BETA-2 RECEPTOR agonist that functions as a BRONCHODILATOR when administered by inhalation. It is used to manage the symptoms… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
STUDY OBJECTIVE To compare the safety of salmeterol xinafoate or placebo added to usual asthma care. DESIGN A 28-week… Expand
  • table 1
  • table 2
  • table 3
  • table 5
  • table 7
Is this relevant?
Highly Cited
2006
Highly Cited
2006
PurposeThe study investigated the role of agglomeration and the effect of fine lactose size on the dispersion of salmeterol… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2004
Highly Cited
2004
The objective of this study was to determine the influence of lactose carrier size on drug dispersion of salmeterol xinafoate (SX… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
AbstractPurpose. The role of fine lactose in the dispersion of salmeterol xina- foate (SX) from lactose mixtures was studied by… Expand
  • figure 2
  • figure 3
  • figure 1
  • table I
  • table II
Is this relevant?
Highly Cited
2001
Highly Cited
2001
CONTEXT Inhaled long-acting beta(2)-agonists improve asthma control when added to inhaled corticosteroid (ICS) therapy… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2001
2001
AbstractPurpose. To characterize two polymorphs of salmeterol xinafoate (SX-I and SX-II) produced by supercritical fluid… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table I
Is this relevant?
Highly Cited
1999
Highly Cited
1999
STUDY OBJECTIVES To examine and compare the efficacy and safety of salmeterol xinafoate, a long-acting inhaled beta2-adrenergic… Expand
  • table 2
  • table 1
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
1997
Highly Cited
1997
  • F E Simons
  • The New England journal of medicine
  • 1997
  • Corpus ID: 21319655
BACKGROUND An inhaled glucocorticoid is currently the medication of choice for long-term control of persistent asthma in children… Expand
Is this relevant?
Highly Cited
1997
Highly Cited
1997
The objectives of this study were to compare the efficacy and safety of salmeterol xinafoate (50 and 100 microg b.i.d.) with that… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Guidelines on asthma management recommend that in patients who still have symptoms on treatment with low-dose inhaled… Expand
Is this relevant?